PROTEIN-KINASE-C AS A MEDIATOR OF TSH AND THYROID AUTOANTIBODY ACTION

被引:16
作者
GINSBERG, J
机构
[1] Division of Endocrinology, 362 Heritage Medical Research Centre, University of Alberta, Edmonton, AB
基金
英国医学研究理事会;
关键词
THYROID; THYROTROPIN; PROTEIN KINASE-C; PHOSPHOINOSITIDE; TSH-RECEPTOR ANTIBODIES;
D O I
10.3109/08916939209014635
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although it is well-established that TSH activates a cAMP-dependent pathway in the thyroid follicular cell leading to thyroid hormone synthesis and release, the present review provides new evidence that TSH also activates a non-cAMP-dependent signal transduction system. This cascade involves phosphoinositide (PI) turnover, diacylglycerol accumulation and protein kinase C (PKC) activation. Activation of this pathway leads to an inhibition of differentiated thyroid function in vitro. Recent evidence suggests that TSH can activate both pathways via a single transcription unit. Unlike TSH, TSH-receptor antibodies may selectively activate cAMP with no effects on PI turnover. In contrast, preliminary studies suggest TSH-blocking antibodies may activate PKC. PKC may be an important mediator of TSH and, possibly, thyroid autoantibody action.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 58 条
[1]  
Rose N.R., Witebsky E., Studies on organ-specificity. V. Changes in the thyroid glands of rabbits following active immunization with rabbit thyroid extract, J. Immunol, 76, pp. 417-427, (1956)
[2]  
Roitt I.M., Doniach D., Campbell R.N., Hudson R.V., Autoantibodies in Hashimoto's disease, Lancet, 2, pp. 820-821, (1956)
[3]  
Adams D.D., Purves H.D., Proc Univ Olago Med Sch, 34, pp. 11-12, (1956)
[4]  
Friedman J.M., Fialkow P.J., Genetic factors in thyroid disease, Werner's the ThyroidFifth Edition, pp. 634-650, (1986)
[5]  
Enders G., Paramyxoviruses, Medical MicrobiologyThird Edition, pp. 769-784, (1991)
[6]  
Carter J.K., Ow C.L., Smith R.E., Rous associated virus type 7 induces a syndrome in chickens characterized by stunting and obesity, Infection and Immunity, 39, pp. 410-422, (1983)
[7]  
Weaver D.K., Nishiyami R.H., Burton W.D., Batsakis J.G., Surgical thyroid disease: a survey before and after iodine prophylaxis, Arch Surg, 92, pp. 796-801, (1966)
[8]  
Boukis M.A., Koutras D.A., Souvatzoglou A., Evangelopoulou A., Vrontakis M., Moulopoulos S.D., Thyroid hormone and immunological studies in endemic goiter, J Clin Endocrin and Metab, 57, pp. 859-862, (1983)
[9]  
Martino E., Safran M., Aghini-Lombardi F., Rajatanavin R., Lenziardi M., Fay M., Pacchiarotti A., Aronin N., Macchia E., Haffajee C., Odoguardi L., Love J., Bigalli A., Baschieri L., Pincher A., Braverman L., Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy, Ann Internal Med, 101, pp. 28-34, (1984)
[10]  
Cole R.K., Kite J.H., Witebsky E., Hereditary autoimmune thyroiditis in the fowl, Science, 2, pp. 1601357-1601358